findmyKOL
Clinical trialNCT05641831RecruitingPhase 2Interventional

Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study

SponsorUma BorateEnrollment110Clonal Cytopenia of Undetermined Significance
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Miami

    Miami, Florida, United States

    Namrata S Chandhok, MD
    Recruiting
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    Tamanna Haque, MD
    Recruiting
  • Weill Cornell Medical College

    New York, New York, United States

    Pinkal Desai, M.D.
    Recruiting
  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

    Uma M. Borate, MD, MS
    Recruiting
  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

    Ashwin Kishtagari, MD
    Recruiting
  • Ut Southwestern Medical Center at Dallas

    Dallas, Texas, United States

    Yazan Madanat, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Feb 2023
Primary completion
31 Dec 2028
Completion
31 Dec 2028
Last update posted
2 Jan 2026
Registered enrollment
110
Registry id
NCT05641831
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.